Arfendazam
Arfendazam is a benzodiazepine derivative that has been marketed under various brand names, including Rhythmy, Arfendazam, and others. It is known for its anxiolytic, anticonvulsant, muscle relaxant, and sedative effects, which are common among drugs in the benzodiazepine class. Arfendazam acts on the central nervous system (CNS) by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABAA receptor, leading to increased neuronal inhibition and CNS depression.
Medical Uses[edit]
Arfendazam is primarily used for the treatment of anxiety disorders, including generalized anxiety disorder (GAD) and panic disorders. It may also be prescribed for the short-term relief of symptoms of excessive anxiety. Due to its muscle relaxant properties, it can be used in the treatment of conditions associated with muscle spasm and stiffness.
Pharmacology[edit]
The pharmacological action of Arfendazam is similar to other benzodiazepines. It enhances the effect of GABA, a major inhibitory neurotransmitter in the brain, by binding to the benzodiazepine site on the GABAA receptor complex. This leads to increased opening of chloride channels, hyperpolarization of neurons, and an overall inhibitory effect on neurotransmission.
Side Effects[edit]
Common side effects of Arfendazam include drowsiness, fatigue, dizziness, blurred vision, and ataxia. Long-term use can lead to tolerance, dependence, and withdrawal symptoms upon cessation. It is important for patients to follow their healthcare provider's instructions closely and to not discontinue use abruptly.
Dependence and Withdrawal[edit]
Like other benzodiazepines, Arfendazam can lead to physical dependence and addiction. Withdrawal symptoms can be severe and include anxiety, agitation, tremors, and seizures. Gradual dose reduction is recommended to minimize withdrawal effects.
Legal Status[edit]
The legal status of Arfendazam varies by country. In some countries, it is a controlled substance due to its potential for abuse and dependence.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
